Immunological features and efficacy of the recombinant subunit vaccine LTB-EMY162 against Echinococcus multilocularis metacestode
- 55 Downloads
Alveolar echinococcosis is a zoonotic disease caused by the infection of the larval stage Echinococcus multilocularis with worldwide distribution especially in the northwest China. It is important to develop a well-tolerated immunoprophylaxis against E. multilocularis for alveolar echinococcosis control. In this study, a prokaryotic expression system for recombinant immunogen LTB-EMY162 was established, and the immunological features, sensitized lymphocyte, IL-4/IFN-γ secreted, prophylactic effect, and therapeutic effect were also evaluated. Arctic Express (DE3) system, Ni2+-charged and molecular sieve chromatography were used to obtain a high-purity 29 kDa protein. The ELISA and lymphocyte proliferation assay showed that LTB-EMY162 induced high-titer specific IgG against EMY162 and E. multilocularis protoscoleces protein in BALB/c mice and promoted sensitized T lymphocyte cell proliferation, and LTB-EMY162 stimulated Th cell to secrete IL-4 and IFN-γ and induced a Th1/Th2 mixed type immunological response. We also found that LTB-EMY162 significantly inhibited the cysts formation by challenging with 1000 E. multilocularis protoscoleces. The growth of protoscoleces and cysts were also significantly decreased by treating with LTB-EMY162 in 1000 protoscoleces intraperitoneal injection therapeutic mice model. In conclusion, we have constructed a subunit vaccine LTB-EMY162 which has prevention and therapeutic effect against E. multilocularis infection.
KeywordsEchinococcus multilocularis Alveolar echinococcosis Subunit vaccine EMY162
We thank all of the staffs for their helpful suggestions and advice during this project. We would like to thank the editor for the helpful comments on the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
All experiments were conducted with adherence to the NIH Guide for the Care and Use of Laboratory Animals, and the protocol was approved by the Animal Ethical and Experimental Committee of Qinghai University (QHDX-2014-07). This article does not contain any studies with human participants performed by any of the authors.
- Batçık OE, A Ö KO, Ekşi MŞ, Bilge T (2016) Cerebral alveolar echinococcosis concomitant with liver and lung lesions in a young adult patient: case report and literature review. Turkiye Parazitol Derg:169–171Google Scholar
- Boubaker G, Hemphill A, Huber CO, Spiliotis M, Babba H, Gottstein B (2015) Prevention and immunotherapy of secondary murine alveolar echinococcosis employing recombinant EmP29 antigen. PLoS Negl Trop Dis 9(6):e0003795. https://doi.org/10.1371/journal.pntd.0003795 CrossRefPubMedPubMedCentralGoogle Scholar
- Clements DA, Gilbert GL (1990) Immunisation for the prevention of Haemophilus influenzae type b infections: a review. Aust NZ J Med 20(6):828–834. https://doi.org/10.1111/j.1445-5994.1990.tb00435.x CrossRefGoogle Scholar
- Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, Watanabe J, Matsumoto J, Nakao R, Wakaguri H, Toyoda A (2009) Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis. Vaccine 27(52):7339–7345. https://doi.org/10.1016/j.vaccine.2009.09.045 CrossRefPubMedGoogle Scholar
- Giraudoux P, Raoul F, Afonso E, Ziadinov I, Yang Y, Li LI, Tiaoying LI, Quéré J, Feng X, Wang Q (2013) Transmission ecosystems of Echinococcus multilocularis in China and Central Asia. Parasitology 140(13 (control of cestode zoonoses in Asia: role of basic and applied science)):1655–1666CrossRefPubMedPubMedCentralGoogle Scholar
- Gottstein B, Müller N, Jr SJC, Vogel M, Tanner I, Seebeck T (1990) Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain. Parasite Immunol 12(2):163–174. https://doi.org/10.1111/j.1365-3024.1990.tb00945.x CrossRefPubMedGoogle Scholar
- Ishizuka EK, Ferreira MJ, Grund LZ, Coutinho EMM, Komegae EN, Cassado AA, Bortoluci KR, Lopes-Ferreira M, Lima C (2012) Role of interplay between IL-4 and IFN-γ in the in regulating M1 macrophage polarization induced by Nattectin. Int Immunopharmacol 14(4):513–522. https://doi.org/10.1016/j.intimp.2012.08.009 CrossRefPubMedGoogle Scholar
- Kamishima T, Harabayashi T, Ishikawa S, Kubota KC, Nonomura K, Omatsu T, Onodera Y, Shirato H, Terae S (2009) Alveolar hydatid disease of the adrenal gland: computed tomography and magnetic resonance imaging findings. Jpn J Radiol 27(5):225–228. https://doi.org/10.1007/s11604-009-0326-3 CrossRefPubMedGoogle Scholar
- Kizaki T, Kobayashi S, Ogasawara K, Day NK, Good RA, Onoé K (1991) Immune suppression induced by protoscoleces of Echinococcus multilocularis in mice. Evidence for the presence of CD8dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J Immunol 147(5):1659PubMedGoogle Scholar
- Klaver AC, Patrias LM, Coffey MP, Finke JM, Loeffler DA (2010) Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding. J Neurosci Methods 187(2):263–269. https://doi.org/10.1016/j.jneumeth.2010.01.018 CrossRefPubMedGoogle Scholar
- Le G, Li X, Feng T, He Y, Xing Y, Deng X, Tao X (2012) Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease a subunit. Appl Microbiol Biotechnol 93(5):1937–1945CrossRefGoogle Scholar
- Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B (2012) Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol 18(13):1448–1458. https://doi.org/10.3748/wjg.v18.i13.1448 CrossRefPubMedPubMedCentralGoogle Scholar
- Turcanu V, Hirst TR, Williams NA (2002) Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. Immunology 106(3):316–325. https://doi.org/10.1046/j.1365-2567.2002.01429.x CrossRefPubMedPubMedCentralGoogle Scholar
- Verweij WR, De HL, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J (1998) Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16(20):2069–2076. https://doi.org/10.1016/S0264-410X(98)00076-0 CrossRefPubMedGoogle Scholar